Pluri(IL:PLUR)
ILAÂ 380.50-0.70 (-0.18%)
IL:PLUR
Pluri similar stocks
ILAÂ 380.50
At close:-0.70 (-0.18%)
Compare Pluri (PLUR) vs. Competitors
1 Followers
Comparison Results
| Name | Price | Market Cap | P/E Ratio | Yearly Gain | Analyst Consensus | Analyst Price Target | Compare | Top Analysts' Price Target | Smart Score | Follow |
|---|---|---|---|---|---|---|---|---|---|---|
| IL:PLURPluri | ILA 380.50 | ILA 48.56M | -0.46 | -74.58% | ― | Unlock the IL:PLUR analyst price target with TipRanks Premium | IL:PLUR | Unlock the IL:PLUR top-analyst price target with TipRanks Premium | ||
| IGCIGC Pharma | $0.18 | $20.54M | -2.14 | -50.56% | Moderate Buy | Unlock the IGC analyst price target with TipRanks Premium | IL:PLUR vs IGC | Unlock the IGC top-analyst price target with TipRanks Premium | ||
| PYPDPolyPid | $6.26 | $127.15M | -4.64 | 74.86% | Strong Buy | Unlock the PYPD analyst price target with TipRanks Premium | IL:PLUR vs PYPD | Unlock the PYPD top-analyst price target with TipRanks Premium | ||
| ANTXAN2 Therapeutics, Inc. | $4.55 | $172.64M | -4.89 | 302.65% | ― | Unlock the ANTX analyst price target with TipRanks Premium | IL:PLUR vs ANTX | Unlock the ANTX top-analyst price target with TipRanks Premium |
Performance Comparison
| Ticker | Company Name | Price | Change | % Change | |
|---|---|---|---|---|---|
| IL:PLUR | Pluri | 380.50 | -931.50 | -71.00% | |
| IGC | IGC Pharma | 0.18 | -0.16 | -48.24% | |
| PYPD | PolyPid | 6.26 | 2.62 | 71.98% | |
| ANTX | AN2 Therapeutics, Inc. | 4.55 | 3.43 | 306.25% |
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
